David McIntyre insider trades

Open-market stock purchases and sales by David McIntyre, Chief Financial Officer at Inhibikase Therapeutics, Inc, from SEC Form 4 filings since Jan 20, 2010.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -82%.

Recent trades

DateStockTradeValue
Jan 5, 2026IKT Inhibikase Therapeutics, IncBought (not open market)—

Companies traded

  • IKT Inhibikase Therapeutics, Inc: other filings, last Jan 5, 2026
  • RCEL Avita Therapeutics, Inc: 2 buys, last Jul 17, 2020
  • HTWR HeartWare International, Inc: 25 sales, last Dec 20, 2011

Get free alerts when David McIntyre files a new trade →